Syndicated Research Studies

Global Bone Grafts and Substitutes Market Overview The global bone grafts and substitutes market was valued at USD 3.16 billion in 2024 and is projected to reach USD 4.60 billion by 2030, expanding at a CAGR of 6.6% from 2025 to 2030. The market growth is primarily driven by the rising demand for synthetic bone substitutes and the increasing number of product approvals by regulatory bodies worldwide. For example, in October 2023, Orthofix Medical Inc., a leading spine and orthopedic solutions company, announced 510(k) clearance and the full commercial launch of OsteoCove, a bioactive synthetic graft. Similarly, in July 2020, Baxter International Inc. received U.S. FDA clearance for its Altapore Shape Bioactive Bone Graft, expanding the company’s Altapore product line. The growing adoption of bone grafts and substitutes is also attributed to their biocompatibility, safety, and osteoconductivity, which facilitate bone healing and regeneration, thereby enhancing patient recovery ...

Bone Grafts And Substitutes Industry Overview The global  bone grafts and substitutes market  size is expected to reach USD 4.94 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.2% from 2022 to 2030. The rising incidence of bone and joint disorders, increasing demand for dental bone grafts, growing requirement for dental bone grafts, and technological advancements are some key factors driving the market. The synthetic material type segment is anticipated to witness significant growth over the forecast period. This growth is due to the lesser risk of disease transmission, better acceptance among patients as compared to allografts, and products’ better biocompatibility. Bone Grafts And Substitutes Market Segmentation Grand View Research has segmented the global bone grafts and substitutes market on the basis of material type, application, and region: Based on the Material Type Insights, the market is segme...